CDC is developing an opioid prescribing guideline to help primary care providers offer safer, more effective care for patients with chronic pain and help reduce misuse, abuse, and overdose from these drugs. The guideline will provide recommendations to primary care providers about the appropriate prescribing of opioid pain medications to improve pain management and patient safety. Recommendations focus on the use of opioids in treating chronic pain (i.e., pain lasting longer than three months or past the time of normal tissue healing). The guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.
The National Center for Injury Prevention and Control (NCIPC) Board of Scientific Counselors (BSC) will meet on Thursday, January 28, 2016 to discuss the draft CDC Guideline for Prescribing Opioids for Chronic Pain, and to hear observations formulated and shared by the Opioid Guideline Workgroup. There will be 90 minutes allotted for public comment during this meeting. Please refer to the Federal Register Notice for further information including specific instructions on how to pre-register to share public comment either in person or by phone.
As a reminder, the public comment period for the draft guideline is open until January 13 onRegulations.gov.
CDC values stakeholder and public engagement and we encourage all stakeholders to provide feedback on the draft guideline. Please forward this announcement to others who may be interested in commenting. CDC appreciates all the feedback we have received to date, and we look forward to receiving further input to improve the way opioids are prescribed to ensure safer, more effective pain management and reduce opioid misuse, abuse, and overdose.